Harvard Medical School & Harvard Pilgrim Health Care Institute, United States
Disclosure information not submitted.
1D-05 - Rapid Surveillance Study to Evaluate Safety of Respiratory Syncytial Virus (RSV) Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States
Sunday, August 24, 202511:30 AM - 11:45 AM ET
SW-2F - Overcoming Challenges in CDM Harmonization from Within-Country Coordination to International Collaboration
Sunday, August 24, 20255:15 PM - 6:45 PM ET
